Alpine Immune Sciences

Revolution Medicines

BioMarin Pharmaceutical

Exact Sciences

Exelixis

Moderna

Crinetics Pharmaceuticals Inc

Roivant Sciences Ltd

Natera

Cerevel Therapeutics Holdings Inc

Direxion Daily S&P Biotech Bull 3X Shares

LABU provides daily 3 times exposure to the S&P Biotechnology Select Industry Index.

ProShares Ultra Bloomberg Crude Oil

Direxion Daily Utilities Bull 3X Shares

While there are many ways to gamble in the equities sector, targeting the best leveraged ETFs for April could be a recipe for success. To be sure, you're going to have to accept a heightened risk profile.

The 3 Best Leveraged ETFs for April 2024

2x Bitcoin Strategy ETF

ProShares Ultra Bloomberg Natural Gas

MicroSectors FANG & Innovation 3X Leveraged ETN

MAX Auto Industry 3X Leveraged ETN

GraniteShares 1.5x Long COIN Daily ETF

Direxion Daily Electric & Autonomous Vehicles Bull 2X Shares

Direxion Daily Semiconductor Bull 3x Shares

AXS 2x Innovation ETF

ProShares Ultra Semiconductors

These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs: 03/03/2024

Leveraged ETFs have a non-linear, unpredictable behavior. Here is a drift dashboard with 22 leveraged ETFs. Direxion Daily S&P Biotech Bull 3X Shares ETF is the worst. LABU is an instrument for seasoned traders with planned entry and exit signals. Without a tested strategy and daily monitoring, it is an accident waiting to happen.

LABU: A Really Bad Drift

Direxion Daily Homebuilders & Supplies Bull 3X Shares

Direxion Daily Retail Bull 3X Shares

U.S. stocks rallied in February, with the S&P 500 and the Nasdaq Composite Index recording the best month in nearly a decade.

5 Best-Performing Leveraged ETFs of February

Direxion Daily S&P Biotech Bear 3X Shares

Since the end of October 2023, the S&P 500 Biotechnology Select Industry Index jumped over 30%. It could maintain its upward trajectory given the early IPO activity in 2024 thus far.

Early IPO Activity Could Spell Bullishness for Biotech Industry

Direxion Daily Regional Banks Bull 3X Shares

The demand for leveraged ETFs have increased as investors seek to register big gains in a short span.

5 Leveraged ETFs That Are Up More Than 50% in December

MicroSectors U.S. Big Banks Index 3X Leveraged ETN

Direxion Daily S&P 500 High Beta Bull 3X Shares

Direxion Daily MSCI Mexico Bull 3X Shares

Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs: 12/17/2023

Seeking Alpha Quant rates LABU as a strong Sell, but I rates it as a Buy due to bullish market conditions. LABU is a leveraged ETF that seeks to track 3x the daily performance of the S&P Biotechnology Select Industry Index. I believe LABU has strong momentum and is outperforming the broad market, making it a favorable investment.

LABU: Buy As The Biotech Sector Starts A New Bull Market (Technical Analysis)

The Direxion Daily S&P Biotech Bull and Bear 3X Shares (LABU) provides 3x daily exposure to a biotechnology index. Levered ETFs like LABU are designed for short-term trading and may suffer tracking errors from positive convexity and volatility decay. LABU can be used as a swing trading tool for experienced traders, taking advantage of positive convexity and macro tailwinds in biotech stocks.

LABU: Tool For Swing Traders

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily Junior Gold Miners Index Bull 2X Shares

ProShares UltraShort Bloomberg Natural Gas

Direxion Daily Gold Miners Index Bull 2X Shares

Direxion Daily FTSE China Bear 3X Shares

Top Performing Leveraged/Inverse ETFs: 12/03/2023

MicroSectors Travel 3X Leveraged ETN

Direxion Daily Small Cap Bull 3x Shares

Top Performing Leveraged/Inverse ETFs: 11/19/2023

Direxion MSCI Daily South Korea Bull 3X Shares

Top Performing Leveraged/Inverse ETFs: 11/05/2023

SPDR S&P 500 ETF Trust

Warren Buffett's Berkshire Hathaway has reached record-high levels of cash, with $157 billion on hand, exceeding Disney's market capitalization. The last time Buffett held record cash levels was in late 2021, ahead of the 2022 market correction. Similar patterns are observed between 2018 and 2023, the only two years when the Fed hit multi-year high Fed funds rates while conducting the largest QT balance sheet reduction in history.

Breakouts Everywhere As Buffett Moves To Record High $157 Billion Cash

Pairing Direxion Daily's S&P Biotech Bull 3X Shares ETF with their S&P Biotech Bear 3X Shares ETF produces a low volatility couple. Shorting both assets is attractive because leveraged assets erode over time due to their higher beta and inability to stay correlated over longer timeframes. The performance of the couple is dependent on the behavior of the underlying, with the short couple expected to lose value during strong trends.

LABU And LABD: Another Attractive Double-Short Pairs Trade

Gilead Sciences

Tekla Healthcare Investors

iShares Nasdaq Biotechnology ETF

Illumina

IQVIA Hlds

Lonza Group AG

Merck

Navistar

Omega Healthcare Investors

Pfizer

Royalty Pharma

Tekla World Healthcare Fund

Wuxi Biologics Cayman Inc

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

The recent IRA list of 10 drug publications is not expected to have a significant impact on big pharma stocks in the near term. The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. Investors can consider diversified biotech indexes or healthcare-focused ETFs for exposure to the biopharma sector.

Biopharma Bounce-Back: From Policy Pains To Profitable Plains

The Direxion Daily S&P Biotech Bull 3x Shares ETF (LABU) is a high-risk, leveraged ETF that aims to yield three times the performance of the S&P Biotechnology Select Industry Index. The biotech sector is known for its volatility, which can significantly impact the performance of LABU. Trading LABU is challenging due to the unpredictable nature of the biotech sector and the path dependence of leveraged ETFs. Investors should use caution and consider alternative investment options.

LABU: A Levered ETF Doomed From The Start

iShares iBoxx High Yield Corporate Bond ETF

ProShares Short QQQ

Invesco QQQ

Direxion Daily Semiconductor Bear 3x Shares

ProShares UltraPro Short QQQ

ProShares UltraPro QQQ

Financial Select Sector SPDR Fund

High trading volume indicates high liquidity, which is a key characteristic of ETFs.

10 Most-Heavily Traded ETFs of the Last Three Months

Direxion Daily Real Estate Bear 3x Shares

Direxion Daily Emerging Markets Bull 3X Shares

The S&P 500 continues to climb higher this summer (up over 16% for the year), offering opportunities that traders can capitalize on when looking at specific sectors and outside domestic equities.

3 Trades to Consider Amid Early Summer Rally

LABU is a 3X leveraged fund that has disappointed the biotech bulls. The sector looks beaten and perhaps cheap relative to long-term prospects. LABU can work for medium term returns if two requirements are met.

LABU: 2 Requirements For Making Money In This Leveraged Biotech Fund

MicroSectors U.S. Big Banks Index -3X Inverse Leveraged ETN

AdvisorShares MSOS 2x Daily ETF

MicroSectors U.S. Big Oil Index -3X Inverse Leveraged ETNs

MicroSectors Oil & Gas Exploration & Production -3X Inverse Leveraged ETN

Advisorshares Poseidon Dynamic Cannabis ETF

ProShares UltraShort Bloomberg Crude Oil

MicroSectors Energy -3X Inverse Leveraged ETN

Top Performing Leveraged/Inverse ETFs: 05/07/2023

Direxion Daily S&P 500 High Beta Bear 3X Shares

Direxion Daily Dow Jones Internet Bear 3X Shares

The month of April was marked by huge volatility. Though recession fears continued to weigh on investors sentiment, cooling inflation and better-than-expected earnings drove the stocks higher.

5 Leveraged/Inverse ETFs That Gained Double Digits in April

SPDR® S&P Biotech ETF, the Biotechnology Select Industry Index ETF, has an extreme short interest of 51.16%. XBI is in an uptrend since May-June 2022. Direxion Daily S&P Biotech Bull 3X Shares ETF, the 3X leveraged Biotech ETF, is rated as a HOLD.

Leveraged Biotech ETFs: Hold LABU, Sell LABD

Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. This ETF attempts to mimic 3X the one-day performance of the SPDR S&P 500 Biotech ETF (NYSE: XBI).

Want Diversified Upside in Biotechnology? Check out LABU

Biotech stocks have pulled back and offer better risk to reward for investors, Direxion Daily S&P Biotech Bull 3x Shares ETF is a popular way to trade them. M&A is likely to drive prices for mid-cap and small-cap biopharma.

LABU: Leveraged Biotech ETF Review

iShares MSCI Emerging Markets ETF

iShares China Large-Cap ETF

ProShares Ultra VIX Short-Term Futures ETF

Thee ETF industry is seeing explosive growth, piling up huge assets amid the stock market turmoil. This has resulted in enough liquidity, with most of the ETFs trading at extremely higher volumes.

10 Most-Heavily Traded ETFs of Fourth-Quarter 2022

News for Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU)